Second primary malignancies in patients with melanoma in situ: Insights from the surveillance, epidemiology, and end results program.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer epidemiology"
DOI: 10.1016/j.canep.2021.101932
Abstract: BACKGROUND Melanoma in situ (MIS) is among the most frequently diagnosed cancers in the United States. Emerging data suggest that MIS is associated with an increased risk of developing a second primary malignancy (SPM). OBJECTIVES… read more here.
Keywords: risk; developing spm; surveillance; risk developing ... See more keywords